تقرير
Siltuximab administration results in spurious IL-6 elevation in peripheral blood.
| العنوان: | Siltuximab administration results in spurious IL-6 elevation in peripheral blood. |
|---|---|
| المؤلفون: | Mango NA; Center for Cytokine Storm Treatment & Laboratory, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Pierson SK; Center for Cytokine Storm Treatment & Laboratory, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Sarmiento Bustamante M; Center for Cytokine Storm Treatment & Laboratory, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Brandstadter JD; Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., van Rhee F; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Fajgenbaum DC; Center for Cytokine Storm Treatment & Laboratory, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. |
| المصدر: | American journal of hematology [Am J Hematol] 2024 Jan; Vol. 99 (1), pp. E15-E18. Date of Electronic Publication: 2023 Oct 23. |
| نوع المنشور: | Letter; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: New York Ny : Wiley-Blackwell Original Publication: New York, Liss. |
| مواضيع طبية MeSH: | Interleukin-6* , Castleman Disease*, Humans ; Antibodies, Monoclonal/therapeutic use |
| References: | Blood Adv. 2022 Aug 23;6(16):4773-4781. (PMID: 35793409) Nat Commun. 2022 Nov 24;13(1):7236. (PMID: 36433996) AAPS J. 2014 Jan;16(1):129-39. (PMID: 24287601) Blood Adv. 2021 Sep 14;5(17):3445-3456. (PMID: 34438448) J Immunol Methods. 2016 Jul;434:1-8. (PMID: 27049586) Blood. 2018 Nov 15;132(20):2115-2124. (PMID: 30181172) |
| معلومات مُعتمدة: | R01 FD007632 United States FD FDA HHS; R01 HL141408 United States HL NHLBI NIH HHS; R01HL141408 United States HL NHLBI NIH HHS |
| المشرفين على المادة: | T4H8FMA7IM (siltuximab) 0 (Interleukin-6) 0 (Antibodies, Monoclonal) |
| تواريخ الأحداث: | Date Created: 20231023 Date Completed: 20231219 Latest Revision: 20240726 |
| رمز التحديث: | 20240726 |
| مُعرف محوري في PubMed: | PMC10998478 |
| DOI: | 10.1002/ajh.27132 |
| PMID: | 37867418 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1096-8652 |
|---|---|
| DOI: | 10.1002/ajh.27132 |